Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized treatment of advanced hepatocellular carcinoma. Integrated use of transarterial chemoembolization (TACE), a locoregional inducer of immunogenic cell death, with ICI has not been formally assessed for safety and efficacy outcomes. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinelli, Brett, Kim, Edward, D'Alessio, Antonio, Cedillo, Mario, Sinha, Ishan, Debnath, Neha, Kudo, Masatoshi, Nishida, Naoshi, Saeed, Anwaar, Hildebrand, Hannah, Kaseb, Ahmed O, Abugabal, Yehia I, Pillai, Anjana, Huang, Yi-Hsiang, Khan, Uqba, Muzaffar, Mahvish, Naqash, Abdul Rafeh, Patel, Rahul, Fischman, Aaron, Bishay, Vivian, Bettinger, Dominik, Sung, Max, Ang, Celina, Schwartz, Myron, Pinato, David J, Marron, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204420/
https://www.ncbi.nlm.nih.gov/pubmed/35710293
http://dx.doi.org/10.1136/jitc-2021-004205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204420/
https://www.ncbi.nlm.nih.gov/pubmed/35710293
http://dx.doi.org/10.1136/jitc-2021-004205

Ejemplares similares